Healthcare Sector Recap: Agilent Technologies (NYSE:A), Athersys (NASDAQ:ATHX) – A, ATHX, OPXA, QCOR, DNDN, UNIS

Investors responded positively to the healthcare stocks on Tuesday. Key movement were observed in Questcor Pharmaceuticals Inc (NASDAQ:QCOR) and Dendreon Corporation (NASDAQ:DNDN) on percentage gainers side while Unilife Corp (NASDAQ:UNIS) was prominent stock on percentage decliner side.

Agilent Technologies Inc (NYSE:A) declared fiscal Q2 earnings moved down 35 percent because of weaker margins and overhauling-related expenses, write-downs and other items. However, adjusted earnings surpassed Wall Street forecasts.

The firm shattered the high end of its EPS outlook and presently forecasts $2.70 to $2.85 for fiscal year on $6.75 billion to $6.85 billion of revenue.

The firm earlier anticipated profit of $2.70 to $3 per-share on $6.9 billion to $7.1 billion of revenue.

Agilent Technologies Inc’s YTD performance was recorded as 7.72% while its market capitalization was $15.26 billion. The company has P/B ratio of 2.86 while P/E ratio was booked as 14.09. Institutional ownership owns 83.02% shares of the company while beta factor, which is used to measure riskiness of the security, was 1.51. Net profit margin of the company was 15.96% while its gross profit margin was 52.30%.

Athersys, Inc (NASDAQ:ATHX) on Tuesday announced fiscal Q1 net loss was $9.4 million or $0.18 a share, evaluated against a net loss of $4.3 million or $0.17 a share in previous year.
Thomson Reuters 2 analysts’ survey on average forecasted a loss of $0.11 a share for three months period.
Quarterly revenues tumbled to $0.3 million from $2.75 million in similar period a year ago, hurt by a drop in Pfizer contract revenues.

Athersys, Inc. has market capitalization of $113.44 billion. Its current ratio was 5.88 while its shares were looking forward SMA50 with 16.68. The company offered earnings per share of -0.48 while its 55.85 million shares were outstanding. YTD performance of the stock was 100.00%.

Opexa Therapeutics Inc (NASDAQ:OPXA) has the market capitalization of $10.43 billion. The company’s EPS was -1.52 while its 7.99 million shares were outstanding. Its institutional ownership was 14.61%. Shares of the company were moving ahead of SMA50 with -6.50% while its YTD performance was 58.77%.

DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with! CLICK HERE TO START YOUR FREE 30-DAY TRIAL

This entry was posted in Healthcare, Latest Headlines and tagged , , , , , , , , , , , , , , , , , . Bookmark the permalink.